These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 30516507
1. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016. Chokoshvili O, Vepkhvadze N, Davitaia T, Tevzadze L, Tsertsvadze T. Georgian Med News; 2018 Oct; (283):123-129. PubMed ID: 30516507 [Abstract] [Full Text] [Related]
2. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome. Chokoshvili O, Lomashvili K, Malakmadze N, Geleishvil M, Brant J, Imnadze P, Chitadze N, Tevzadze L, Chanturia G, Tevdoradze T, Tsertsvadze T, Talkington D, Mody RK, Strockbine N, Gerber RA, Maes E, Rush T. J Epidemiol Glob Health; 2014 Dec; 4(4):249-59. PubMed ID: 25455642 [Abstract] [Full Text] [Related]
3. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network. Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network. J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890 [Abstract] [Full Text] [Related]
4. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S. Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137 [Abstract] [Full Text] [Related]
5. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli. Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM, Griffin PM. Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280 [Abstract] [Full Text] [Related]
6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI. Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [Abstract] [Full Text] [Related]
7. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance. Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. BMC Infect Dis; 2014 May 16; 14():265. PubMed ID: 24884396 [Abstract] [Full Text] [Related]
13. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011. Werber D, King LA, Müller L, Follin P, Buchholz U, Bernard H, Rosner B, Ethelberg S, de Valk H, Höhle M. Am J Epidemiol; 2013 Sep 15; 178(6):984-92. PubMed ID: 23935124 [Abstract] [Full Text] [Related]
14. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A. BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224 [Abstract] [Full Text] [Related]
16. Vacation in Egypt associated with Shiga toxin-producing Escherichia coli infection in children and adolescents, northern Italy, 2023. Ria T, Mancuso MC, Daprai L, Liporace MF, Gazzola A, Arnaboldi S, Vianello F, Luini M, Consonni D, Ardissino G, ItalKid-HUS NetworkThe members of the ItalKid-HUS Network are acknowledged at the end of the article.. Euro Surveill; 2024 Jul 13; 29(30):. PubMed ID: 39056198 [Abstract] [Full Text] [Related]
18. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network. Ardissino G, Possenti I, Vignati C, Daprai L, Capone V, Brigotti M, Luini MV, Consonni D, Montini G. Pediatr Nephrol; 2020 Oct 13; 35(10):1997-2001. PubMed ID: 32734345 [Abstract] [Full Text] [Related]
19. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016. Bruyand M, Mariani-Kurkdjian P, Le Hello S, King LA, Van Cauteren D, Lefevre S, Gouali M, Jourdan-da Silva N, Mailles A, Donguy MP, Loukiadis E, Sergentet-Thevenot D, Loirat C, Bonacorsi S, Weill FX, De Valk H, Réseau français hospitalier de surveillance du SHU pédiatriqueMembers of the Réseau français hospitalier de surveillance du SHU pédiatrique have been listed at the end of the article.. Euro Surveill; 2019 Feb 13; 24(8):. PubMed ID: 30808442 [Abstract] [Full Text] [Related]
20. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome. Peco-Antić A. Srp Arh Celok Lek; 2016 Feb 13; 144(11-12):664-9. PubMed ID: 29659236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]